Loading…
Reported covered position: Intern, Rep. Boehlert
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2026 · third_quarter · Q3
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act; S. 1414, Expedited Access to Biosimilars Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act; S. 1414, Expedited Access to Biosimilars Act.
PBM Reform Act of 2025
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act; S. 1414, Expedited Access to Biosimilars Act.
PBM Reform Act of 2025
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act.
PBM Reform Act of 2025
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."
340B ACCESS Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."
340B ACCESS Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act.
340B ACCESS Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act; S. 1414, Expedited Access to Biosimilars Act.
Drug Competition Enhancement Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act.
Drug Competition Enhancement Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."
Drug Competition Enhancement Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act; S. 1414, Expedited Access to Biosimilars Act.
Expedited Access to Biosimilars Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act; S. 1414, Expedited Access to Biosimilars Act.
Medication Affordability and Patent Integrity Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act; S. 1414, Expedited Access to Biosimilars Act.
Medication Affordability and Patent Integrity Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act.
PBM Price Transparency and Accountability Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act; S. 1414, Expedited Access to Biosimilars Act.
PBM Price Transparency and Accountability Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act.
PBM Price Transparency and Accountability Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, and employment issues, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program;
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" Urged Members and Staff to attend a congressional presentation on US construction jobs in the pharmaceutical industry;
PBM Reform Act of 2025
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" Urged Members and Staff to attend a congressional presentation on US construction jobs in the pharmaceutical industry;
PBM Reform Act of 2025
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."
340B ACCESS Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" Urged Members and Staff to attend a congressional presentation on US construction jobs in the pharmaceutical industry;
340B ACCESS Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."
Drug Competition Enhancement Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, and employment issues, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program;
Drug Competition Enhancement Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program
Drug Competition Enhancement Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" Urged Members and Staff to attend a congressional presentation on US construction jobs in the pharmaceutical industry;
Drug Competition Enhancement Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."
PBM Price Transparency and Accountability Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."
American Relief Act, 2025
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act; HR 10545, American Relief Act, 2025.
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act; HR 10545, American Relief Act, 2025.
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act
Lowering Drug Costs for American Families Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Lowering Drug Costs for American Families Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Lowering Drug Costs for American Families Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Lowering Drug Costs for American Families Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act; HR 10545, American Relief Act, 2025.
Lowering Drug Costs for American Families Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act; HR 10545, American Relief Act, 2025.
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act; HR 10545, American Relief Act, 2025.
HELP Copays Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act
HELP Copays Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act; HR 10545, American Relief Act, 2025.
HELP Copays Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
HELP Copays Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
HELP Copays Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Prescription Pricing for the People Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Prescription Pricing for the People Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Prescription Pricing for the People Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Prescription Pricing for the People Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act; HR 10545, American Relief Act, 2025.
Prescription Pricing for the People Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act; HR 10545, American Relief Act, 2025.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act; HR 10545, American Relief Act, 2025.
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
Lowering Drug Costs for American Families Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
Lowering Drug Costs for American Families Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
HELP Copays Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act").
HELP Copays Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
HELP Copays Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
Prescription Pricing for the People Act of 2023
Client: HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023.
Prescription Pricing for the People Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
Prescription Pricing for the People Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023
Prescription Pricing for the People Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
Prescription Pricing for the People Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act").
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act").
Pharmacy Benefit Manager Transparency Act of 2023
Client: HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act").
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 3, Elijah E. Cummings Lower Drug Costs Now Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 3, Elijah E. Cummings Lower Drug Costs Now Act.
Inflation Reduction Act of 2022
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 5376, Build Back Better Act.
Inflation Reduction Act of 2022
Client: HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 5376, Build Back Better Act
Patient Protection and Affordable Care Enhancement Act
Client: PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; H.R.1425 - Patient Protection and Affordable Care Enhancement Act
Patient Protection and Affordable Care Enhancement Act
Client: HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; H.R.1425 - Patient Protection and Affordable Care Enhancement Act
Medicare Negotiation and Competitive Licensing Act of 2019
Client: HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 1046, Medicare Negotiation and Competitive Licensing Act of 2019.
Elijah E. Cummings Lower Drug Costs Now Act
Client: HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) · Firm: E3 STRATEGIC CONSULTING GROUP
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally. HR 3, Lower Drug Costs Now Act of 2019.
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2026 · second_quarter · Q2
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act"; S. 3345, "PBM Price Transparency and Accountability Act"; S. 2658, Medication Affordability and Patent Integrity Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2026 · first_quarter · Q1
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."
Filing targets: HOUSE OF REPRESENTATIVES
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2025 · fourth_quarter · Q4
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2025 · third_quarter · Q3
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" Urged Members and Staff to attend a congressional presentation on US construction jobs in the pharmaceutical industry;
Filing targets: HOUSE OF REPRESENTATIVES
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2025 · second_quarter · Q2
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2025 · first_quarter · Q1
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, and employment issues, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2024 · fourth_quarter · Q4
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act; HR 10545, American Relief Act, 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2024 · third_quarter · Q3
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via E3 STRATEGIC CONSULTING GROUP
2024 · third_quarter · RR
Research and funding for client's products;
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2024 · second_quarter · Q2
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2024 · first_quarter · Q1
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2024 · first_quarter · Q1
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2023 · fourth_quarter · Q4
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2023 · third_quarter · Q3
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2023 · second_quarter · Q2
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act").
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2023 · first_quarter · Q1
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2023 · first_quarter · 1T
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2022 · fourth_quarter · Q4
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally;
Filing targets: SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2022 · fourth_quarter · Q4
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally;
Filing targets: SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2022 · third_quarter · Q3
Monitoring prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2022 · third_quarter · Q3
Monitoring prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2022 · second_quarter · Q2
Monitoring prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2022 · second_quarter · Q2
Monitoring prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2022 · first_quarter · Q1
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally;
Filing targets: HOUSE OF REPRESENTATIVES
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2022 · first_quarter · Q1
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally;
Filing targets: HOUSE OF REPRESENTATIVES
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2021 · fourth_quarter · Q4
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 5376, Build Back Better Act.
Filing targets: SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2021 · fourth_quarter · Q4
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 5376, Build Back Better Act
Filing targets: SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2021 · third_quarter · Q3
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2021 · third_quarter · Q3
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2021 · second_quarter · Q2
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 3, Elijah E. Cummings Lower Drug Costs Now Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2021 · second_quarter · Q2
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 3, Elijah E. Cummings Lower Drug Costs Now Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2021 · first_quarter · Q1
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally.
Filing targets: SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2021 · first_quarter · Q1
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally.
Filing targets: SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2020 · fourth_quarter · Q4
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally.
Filing targets: HOUSE OF REPRESENTATIVES
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2020 · fourth_quarter · Q4
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally.
Filing targets: HOUSE OF REPRESENTATIVES
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2020 · third_quarter · Q3
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2020 · third_quarter · Q3
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2020 · second_quarter · Q2
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; H.R.1425 - Patient Protection and Affordable Care Enhancement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2020 · second_quarter · Q2
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; H.R.1425 - Patient Protection and Affordable Care Enhancement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2020 · first_quarter · Q1
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2020 · first_quarter · Q1
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2019 · fourth_quarter · Q4
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally. HR 3, Lower Drug Costs Now Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2019 · fourth_quarter · Q4
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally. HR 3, Lower Drug Costs Now Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION via E3 STRATEGIC CONSULTING GROUP
2019 · fourth_quarter · RR
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry. HR 3, Lower Drug Costs Now Act of 2019.
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2019 · third_quarter · Q3
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally. HR 3, Lower Drug Costs Now Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2019 · second_quarter · Q2
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2019 · first_quarter · Q1
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 1046, Medicare Negotiation and Competitive Licensing Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2018 · fourth_quarter · Q4
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2018 · third_quarter · Q3
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) via E3 STRATEGIC CONSULTING GROUP
2018 · third_quarter · RR
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry.
Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry.
HEINZ STRATEGIES LLC (ON BEHALF UNITED BROTHERHOOD OF CARPENTERS & JOINERS) via E3 STRATEGIC CONSULTING GROUP
2018 · second_quarter · Q2
Forest service and the Job Corps program.
Filing targets: SENATE
HEINZ STRATEGIES LLC (ON BEHALF UNITED BROTHERHOOD OF CARPENTERS & JOINERS) via E3 STRATEGIC CONSULTING GROUP
2018 · first_quarter · Q1
Timber issues relating to small businesses, including a federal rule entitled Small Business Government Contracting and Timber Sales Amendment.
Pensions and retirement security, generally; H.R.4997 - GROW Act (multi-employer pensions).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF UNITED BROTHERHOOD OF CARPENTERS & JOINERS) via E3 STRATEGIC CONSULTING GROUP
2017 · fourth_quarter · Q4
Pensions and retirement security, generally; draft proposal on multi-employer pensions.
Timber issues relating to small businesses, including a federal rule entitled Small Business Government Contracting and Timber Sales Amendment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF UNITED BROTHERHOOD OF CARPENTERS & JOINERS) via E3 STRATEGIC CONSULTING GROUP
2017 · third_quarter · Q3
Timber issues relating to small businesses, including a federal rule entitled Small Business Government Contracting and Timber Sales Amendment.
Pensions and retirement security, generally; draft proposal on multi-employer pensions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF UNITED BROTHERHOOD OF CARPENTERS & JOINERS) via E3 STRATEGIC CONSULTING GROUP
2017 · second_quarter · Q2
Timber issues relating to small businesses, including a federal rule entitled Small Business Government Contracting and Timber Sales Amendment.
Pensions and retirement security, generally; draft proposal on multi-employer pensions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF UNITED BROTHERHOOD OF CARPENTERS & JOINERS) via E3 STRATEGIC CONSULTING GROUP
2017 · first_quarter · Q1
Pensions and retirement security, generally; draft proposal on multi-employer pensions.
Timber issues relating to small businesses, including a federal rule entitled Small Business Government Contracting and Timber Sales Amendment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF UNITED BROTHERHOOD OF CARPENTERS & JOINERS) via E3 STRATEGIC CONSULTING GROUP
2016 · fourth_quarter · Q4
Timber issues relating to small businesses, including a federal rule entitled Small Business Government Contracting and Timber Sales Amendment.
Pensions and retirement security, generally; draft proposal on multiemployer pensions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEINZ STRATEGIES LLC (ON BEHALF UNITED BROTHERHOOD OF CARPENTERS & JOINERS) via E3 STRATEGIC CONSULTING GROUP
2016 · third_quarter · Q3
Timber issues relating to small businesses, including a federal rule entitled Small Business Government Contracting and Timber Sales Amendment.
Pensions and retirement security, generally; draft proposal on multiemployer pensions.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB)
HEINZ STRATEGIES LLC (ON BEHALF UNITED BROTHERHOOD OF CARPENTERS & JOINERS) via E3 STRATEGIC CONSULTING GROUP
2016 · second_quarter · Q2
Pensions and retirement security
Filing targets: HOUSE OF REPRESENTATIVES
HEINZ STRATEGIES LLC (ON BEHALF UNITED BROTHERHOOD OF CARPENTERS & JOINERS) via E3 STRATEGIC CONSULTING GROUP
2016 · second_quarter · RR
Pensions and retirement security